AI assistant
Sending…
IN8BIO, INC. — Director's Dealing 2023
Apr 18, 2023
35200_dirs_2023-04-18_0b244cc1-e7dd-46ed-8a69-17fa5b84d802.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: IN8BIO, INC. (INAB)
CIK: 0001740279
Period of Report: 2023-04-14
Reporting Person: Ho William Tai-Wei (Director, President and CEO, 10% Owner)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2023-04-14 | Employee Stock Option (right to buy) | $1.34 | A | 393950 | Acquired | 2028-04-14 | Common Stock (393950) | Direct |
Footnotes
F1: Twenty-five percent (25%) of the shares subject to the option shall vest on April 14, 2024 and the remaining shares subject to the option shall vest in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person continuing to provide service through each such date.
More from IN8BIO, INC.
Regulatory Filings
2026
Jun 1
Regulatory Filings
2026
Jun 1
Regulatory Filings
2026
May 18
Regulatory Filings
2026
May 7
Regulatory Filings
2026
May 7
Regulatory Filings
2026
May 7
Regulatory Filings
2026
May 7
Regulatory Filings
2026
May 7
Regulatory Filings
2026
May 7
Regulatory Filings
2026
May 7